HCA Healthcare, Inc. (HCA) Stock Analysis
Falling Knife setup
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $361.32, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Florida and Texas; Weak growth.
HCA Healthcare operates 190 hospitals (179 acute care, 7 behavioral, 4 rehab), 121 freestanding ASCs, and 31 endoscopy centers across 19 US states and England, generating $75.6 billion in 2025 revenues. Revenue comes primarily from managed care/private insurers (48.9%), Medicare... Read more
Hold if already holding. Not a fresh buy at $361.32, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Florida and Texas; Weak growth. Chart setup: Death cross, below all MAs, RSI 14, MACD bearish. Maintain position. Not compelling to add more. Score 5.5/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, earnings proximity 46d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: moderate.
Recent developments
updated 2026-06-09Recent Developments — HCA Healthcare, Inc.
Latest news
- NEWS Robert W. Baird Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat — MarketBeat negative
- NEWS Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com — Investing.com positive
- NEWS HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch — MarketWatch positive
- NEWS How To Earn $500 A Month From HCA Healthcare Stock Ahead Of Q1 Earnings - Benzinga — Benzinga positive
- NEWS Universal Beteiligungs und Servicegesellschaft mbH Sells 11,258 Shares of HCA Healthcare, Inc. $HCA - MarketBeat — MarketBeat neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicFlorida and Texas10-K Item 1: 'Our facilities are heavily concentrated in Florida and Texas, which makes us sensitive to regulatory, economic, public health, environmental and competitive conditions and changes in those states.'
Material Events(8-K, last 90d)
- 2026-02-25Item 5.02LOWHCA Compensation Committee adopted the 2026 Executive Officer Performance Excellence Program on Feb 24, 2026, setting performance award opportunities (80% EBITDA targets, 20% quality metrics) for named executive officers including CEO (175% of base salary) and CFO/COO (125% of base salary).SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $361.32, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: Florida and Texas; Weak growth. Chart setup: Death cross, below all MAs, RSI 14, MACD bearish. Maintain position. Not compelling to add more. Target $456.00 (+26.2%), stop $346.18 (−4.4%), A.R:R 4.1:1. Score 5.5/10, moderate confidence.
Take-profit target: $456.00 (+26.2% upside). Target $456.00 (+26.2%), stop $346.18 (−4.4%), A.R:R 4.1:1. Stop-loss: $346.18.
Concentration risk — Geographic: Florida and Texas; Weak growth; Negative momentum.
HCA Healthcare, Inc. trades at a P/E of 12.8 (forward 11.2). TrendMatrix value score: 8.2/10. Verdict: Hold.
30 analysts cover HCA with a consensus score of 3.8/5. Average price target: $507.
What does HCA Healthcare, Inc. do?HCA Healthcare operates 190 hospitals (179 acute care, 7 behavioral, 4 rehab), 121 freestanding ASCs, and 31 endoscopy...
HCA Healthcare operates 190 hospitals (179 acute care, 7 behavioral, 4 rehab), 121 freestanding ASCs, and 31 endoscopy centers across 19 US states and England, generating $75.6 billion in 2025 revenues. Revenue comes primarily from managed care/private insurers (48.9%), Medicare (32.7% combined), and Medicaid (12.7% combined). Facilities are heavily concentrated in Florida and Texas.